Ihuman Net Income From Continuing Ops from 2010 to 2026

IH Stock  USD 2.00  0.02  1.01%   
Ihuman's Net Income From Continuing Ops is increasing with slightly volatile movements from year to year. Net Income From Continuing Ops is estimated to finish at about 119 M this year. For the period between 2010 and 2026, Ihuman, Net Income From Continuing Ops quarterly trend regression had mean deviation of  69,409,044 and range of 458.7 M. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2019-12-31
Previous Quarter
31.9 M
Current Value
21.6 M
Quarterly Volatility
25.5 M
 
Covid
 
Interest Hikes
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 11.2 M, Depreciation And Amortization of 16.5 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 0.15, Dividend Yield of 0.26 or PTB Ratio of 0.13. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Build AI portfolio with Ihuman Stock
Check out the analysis of Ihuman Correlation against competitors.
The Net Income From Continuing Ops trend for Ihuman Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Ihuman is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Ihuman's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Ihuman Inc over the last few years. It is Ihuman's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Ihuman Net Income From Continuing Ops Regression Statistics

Arithmetic Mean6,784,739
Geometric Mean39,922,452
Coefficient Of Variation1,488
Mean Deviation69,409,044
Median(17,604,000)
Standard Deviation100,951,156
Sample Variance10191.1T
Range458.7M
R-Value0.47
Mean Square Error8430.7T
R-Squared0.22
Significance0.05
Slope9,471,098
Total Sum of Squares163058.2T

Ihuman Net Income From Continuing Ops History

2026119 M
2025113.4 M
202498.6 M
2023183.1 M
2022109.8 M
2021-37.1 M
2020-37.5 M

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Income From Continuing Ops113.4 M119 M

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is there potential for Hotels, Restaurants & Leisure market expansion? Will Ihuman introduce new products? Factors like these will boost the valuation of Ihuman. Market participants price Ihuman higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.11)
Earnings Share
0.28
Revenue Per Share
16.441
Quarterly Revenue Growth
(0.14)
Return On Assets
0.0326
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Ihuman's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.